While the labour market may be tight for the pharmaceutical industry, organisations can get ahead of growing pains by prioritising their people. Growing a strong and stable staff is possible ...

Co. withdrew the painkiller Vioxx from the market last September after the drug was linked to increased risks of heart attack and stroke, more than one metabolomics researcher shook their heads and ...

About 80 million Americans fill prescriptions each year for medications to treat new instances of moderate to severe pain, ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

In December 2017, the US Food & Drug Administration (FDA) approved Luxturna from Spark Therapeutics — the first gene therapy to win market approval in the US. Several other gene therapy programs ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...